
Commentary|Podcasts|January 31, 2025
New Opportunities in Topical Glaucoma Management
Author(s)Mitch Ibach, OD, FAAO, Jessica Steen, OD, FAAO
A newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.
Advertisement
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Fitting the future: How technology is refining specialty lens care
2
Sydnexis releases phase 3 STAR trial results on SYD-101 0.01% for slowing myopia progression
3
South Korea's MFDS receives NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia
4
Study examines association between air pollutants and dry eye via gene involvement
5


















































.png)


